NADPH oxidase inhibitors: a patent review (Q37873495)

24 August 2017

1 reference

title

NADPH oxidase inhibitors: a patent review (English)

1 reference

24 August 2017

Jung-Ae Kim

1

1 reference

24 August 2017

Ganesh Prasad Neupane

2

1 reference

24 August 2017

Eung Seok Lee

3

1 reference

24 August 2017

Byeong-Seon Jeong

4

1 reference

24 August 2017

Byung Chul Park

5

1 reference

24 August 2017

Pritam Thapa

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

10 May 2011

1 reference

Expert Opinion on Therapeutic Patents

24 August 2017

1 reference

24 August 2017

21

1 reference

24 August 2017

8

1 reference

24 August 2017

1147-1158

1 reference

Mitochondria, oxidants, and aging

24 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Physiological roles of xanthine oxidoreductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Reactive oxygen radicals in signaling and damage in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Mammalian peroxisomes and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Regulation and termination of NADPH oxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Molecular composition and regulation of the Nox family NAD(P)H oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Role of Nox family NADPH oxidases in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Identification of a superoxide-generating NADPH oxidase system in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Cell transformation by the superoxide-generating oxidase Mox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NADPH oxidases: new kids on the block

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NOX enzymes and the biology of reactive oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

The Nox family of NAD(P)H oxidases: host defense and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Vascular NAD(P)H oxidases: specific features, expression, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Enzymic mechanisms of superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NADPH oxidase inhibitors: new antihypertensive agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Suppressing renal NADPH oxidase to treat diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Increased Nox1 and hydrogen peroxide in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Identification of renox, an NAD(P)H oxidase in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NOX enzymes as novel targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NADPH oxidases in lung biology and pathology: host defense enzymes, and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Expression of Nox4 in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Diapocynin versus apocynin as pretranscriptional inhibitors of NADPH oxidase and cytokine production by peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

Receptor activation of NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.584870

10.1517/13543776.2011.584870

21 January 2018

Identifiers

DOI

1 reference

release_oyfpelnb7vgrjhhqac3ezbp7he

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oyfpelnb7vgrjhhqac3ezbp7he

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference